Binhua Zou

1.1k total citations · 1 hit paper
23 papers, 927 citations indexed

About

Binhua Zou is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Binhua Zou has authored 23 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Biomaterials. Recurrent topics in Binhua Zou's work include Bone Metabolism and Diseases (9 papers), Bone health and treatments (6 papers) and Nanoparticle-Based Drug Delivery (4 papers). Binhua Zou is often cited by papers focused on Bone Metabolism and Diseases (9 papers), Bone health and treatments (6 papers) and Nanoparticle-Based Drug Delivery (4 papers). Binhua Zou collaborates with scholars based in China, Macao and United States. Binhua Zou's co-authors include Zhiqiang Yu, Meng Yu, Tianfeng Chen, Xiaojuan Li, Yanhui Tan, Ling Yu, Yuanyuan Yang, Qin Yang, Zushuang Xiong and Yu Shrike Zhang and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Biomaterials.

In The Last Decade

Binhua Zou

20 papers receiving 919 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral Hydrogel Microbeads-Mediated In Situ Synthesis of Selenoproteins for Regulating Intestinal Immunity and Microbiota

2023 135 citations Jiang Ouyang, Bo Deng et al. Journal of the American Chemical Society profile →

Peers

Countries citing papers authored by Binhua Zou

Since Specialization

Citations

This map shows the geographic impact of Binhua Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binhua Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binhua Zou more than expected).

Fields of papers citing papers by Binhua Zou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binhua Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binhua Zou. The network helps show where Binhua Zou may publish in the future.

Co-authorship network of co-authors of Binhua Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Binhua Zou. A scholar is included among the top collaborators of Binhua Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binhua Zou. Binhua Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Osteoclast precursor cell-derived Flot2 is a novel therapeutic target for bone loss diseases 2025 ·Pharmacological Research ·Binhua Zou, (unknown), Weili He, Yan Chen, Lihong Li, (unknown), (unknown), (unknown), Xiaojuan Li	0
2	Maintaining cardiac homeostasis by translational selenium nanoparticles with rapid selenoproteins regulation to achieve radiation-induced heart prevention 2025 ·Chemical Engineering Journal ·(unknown), (unknown), Dina Huang, Hongwei Huang, Binhua Zou, Wei Huang, Tianfeng Chen	6
3	Moxibustion ameliorates abnormal subchondral bone remodeling by promoting ACSL1-mediated autophagy to degrade NLRP3 in osteoarthritis 2025 ·Chinese Medicine ·Xuelan Chen, Liping Fu, Yü Huang, Qing Liao, Binhua Zou, Lixia Yuan, Gang Liu	0
4	Rapid Selenoprotein Activation by Selenium Nanoparticles to Suppresses Osteoclastogenesis and Pathological Bone Loss 2024 ·Advanced Materials ·Binhua Zou, Zushuang Xiong, (unknown), (unknown), Xiaoling Li, Tianfeng Chen	39
5	Moxibustion ameliorates osteoarthritis by regulating gut microbiota via impacting cAMP-related signaling pathway 2023 ·Biomedicine & Pharmacotherapy ·Liping Fu, (unknown), (unknown), Xuelan Chen, Binhua Zou, Li‐Xia Yuan, Gang Liu	12
6	Polyphyllin VII protects from breast cancer-induced osteolysis by suppressing osteoclastogenesis via c-Fos/NFATc1 signaling 2023 ·International Immunopharmacology ·(unknown), Jingyun Guo, (unknown), Yan Chen, Binhua Zou, (unknown), (unknown), Yiyuan Wang, Lihong Li, (unknown), (unknown), (unknown), Fengsheng Chen, Xiaojuan Li	7
7	PD-L1-driven efficient enrichment and elimination of circulating cancer cells by magnetic MoSe2 nanosheet 2023 ·Nano Research ·Hongjie Huang, Binhua Zou, (unknown), Xingchen Zhang, Jiale Huang, Jinlin Wang, Xiaoling Li, Tianfeng Chen	3
8	Oral Hydrogel Microbeads-Mediated In Situ Synthesis of Selenoproteins for Regulating Intestinal Immunity and Microbiota breakdown → 2023 ·Journal of the American Chemical Society ·Jiang Ouyang, Bo Deng, Binhua Zou, Yongjiang Li, (unknown), Yuan Tian, Mingkai Chen, Wei Chen, Na Kong, Tianfeng Chen, Wei Tao	135
9	Reversing breast cancer bone metastasis by metal organic framework-capped nanotherapeutics via suppressing osteoclastogenesis 2022 ·Biomaterials ·Binhua Zou, Zushuang Xiong, Lizhen He, Tianfeng Chen	58
10	Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy 2021 ·Acta Pharmaceutica Sinica B ·Ling Yu, Zhenjie Wang, Zhuomao Mo, Binhua Zou, Yuanyuan Yang, Rui Sun, Wen Ma, Meng Yu, Shijun Zhang, Zhiqiang Yu	137
11	Dendrobine attenuates osteoclast differentiation through modulating ROS/NFATc1/ MMP9 pathway and prevents inflammatory bone destruction 2021 ·Phytomedicine ·(unknown), (unknown), Yiyuan Wang, Binhua Zou, (unknown), Yanhui Tan, Qin Yang, (unknown), Yan Chen, Song Wang, Xiaojuan Li	46
12	Oridonin ameliorates inflammation-induced bone loss in mice via suppressing DC-STAMP expression 2020 ·Acta Pharmacologica Sinica ·Binhua Zou, Yanhui Tan, (unknown), (unknown), Qin Yang, (unknown), (unknown), Xiaojuan Li	20
13	Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca2+-NFATc1 and Cav-1 signaling pathways 2020 ·Phytomedicine ·Binhua Zou, (unknown), (unknown), Yanhui Tan, Ligang Jie, Yuan Qu, Qin Yang, (unknown), (unknown), Yan Chen, Qinghong Yu, Xiaojuan Li	34
14	A marine fungus‐derived nitrobenzoyl sesquiterpenoid suppresses receptor activator of NF‐κB ligand‐induced osteoclastogenesis and inflammatory bone destruction 2020 ·British Journal of Pharmacology ·Yanhui Tan, (unknown), Yueyang Zhang, (unknown), Binhua Zou, Xiaowei Luo, Jianbin Su, Yiyuan Wang, (unknown), Kutty Selva Nandakumar, Yonghong Liu, Xuefeng Zhou, Xiaojuan Li	31
15	Ent-kauranes from the Chinese Excoecaria agallocha L. and NF-κB inhibitory activity 2019 ·Fitoterapia ·Zhongping Jiang, Binhua Zou, Xiaojuan Li, Junjun Liu, Li Shen, Jun Wu	8
16	Sinomenine inhibits osteolysis in breast cancer by reducing IL-8/CXCR1 and c-Fos/NFATc1 signaling 2019 ·Pharmacological Research ·Yueyang Zhang, Binhua Zou, Yanhui Tan, (unknown), Yiyuan Wang, (unknown), Lei Tao, Hua Zhou, Liang Liu, Xiaojuan Li	32
17	A mutation of cysteine 46 in IKK-β promotes mPGES-1 and caveolin-1 expression to exacerbate osteoclast differentiation and osteolysis 2019 ·Biochemical Pharmacology ·Binhua Zou, Yueyang Zhang, Ting Li, Juan Liu, (unknown), Yanhui Tan, Qin Yang, (unknown), (unknown), (unknown), Hudan Pan, Xiaojuan Li, Liang Liu	7
18	Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4/TRAF6 and PLCγ1-Ca2+-NFATc1 signaling pathway 2019 ·Acta Pharmacologica Sinica ·Xiangzhou Zeng, (unknown), Qin Yang, Song Wang, Binhua Zou, Yanhui Tan, Min Zou, Shuwen Liu, Xiaojuan Li	97
19	IL-10-producing regulatory B cells exhibit functional defects and play a protective role in severe endotoxic shock 2019 ·Pharmacological Research ·Lei Tao, (unknown), (unknown), (unknown), Qin Yang, (unknown), Binhua Zou, Yanhui Tan, (unknown), Xiaojuan Li	12
20	TLR4 supports the expansion of FasL + CD5 + CD1d hi regulatory B cells, which decreases in contact hypersensitivity 2017 ·Molecular Immunology ·(unknown), Lei Tao, (unknown), Yueyang Zhang, Binhua Zou, Yiyuan Wang, Min Zou, Nana Chen, Lin-sheng Lei, Xiaojuan Li	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact